Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-17-051784)

Filing Details

Accession Number:: 0001144204-17-051784
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-10-10 08:36:10
Reporting Period:: 2017-10-04

Accepted Time:: 2017-10-10 08:36:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1644963	Avenue Therapeutics Inc.	ATXI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
941841	Md A Lindsay Rosenwald	C/O Avenue Therapeutics, Inc. 2 Gansevoort Street, 9Th Floor New York NY 10014		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-10-04	2,200	$5.60	12,200	No	4	P	Direct
Common Stock	Acquisiton	2017-10-05	3,550	$5.60	15,750	No	4	P	Direct
Common Stock	Acquisiton	2017-10-06	2,900	$5.63	18,650	No	4	P	Direct
Common Stock	Acquisiton	2017-10-09	1,350	$5.40	20,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Includes 10,000 shares of restricted stock.